• Influence of radiolysis on astatine-211 chemistry
    Ghalei M, Khoshouei PM, Vandenborre J, Guérard F, Blain G, Zarei M, Haddad F, Fattahi M (P-169)
    iSRS 2022 (24th international Symposium of Radiopharmaceuticals Sciences), Nantes, France, May 29 – June 2, 2022

  • Reduced toxicity of alpha particles at Ultra-High Dose Rate in Zebrafish empryos
    Y. Ghannam, G. Saade, S. Chiavassa, C. Koumeir, G. Blain, M. Evin, Q. Mouchard, F. Haddad, L. Maigne, N. Servagent, G. Delpon, S. Supiot, V. Potiron
    2nd Flash Radiotherapy and Particle Therapy Conference, 30 November-2 Décember 2022, Barcelona, Spain

  • Reduction of Radiotoxcicity by Ultra-High Dose Rate Protontherapy
    G. Saade E. Bogaerts, S. Chiavassa, G. Blain, G. Delpon, M. Evin, Y. Ghannam, F. Haddad, K. Haustermans, C. Koumeir, E. Mavaeva, L. Maigne, Q. Mouchard, N. Servagent, E. Sterpin, S. Supiot, V. Potiron.
    2nd Flash Radiotherapy and Particle Therapy Conference, 30 November-2 Décember 2022, Barcelona, Spain
    hal-03886326

  • Upgrade of the FLASH beam monitoring system at ARRONAX Cyclotron
    Q. Mouchard, N. Servagent, C. Koumeir, G. Blain, A. Bongrand, S. Chiavassa, S. Deffet, G. Delpon, M. Evin, A. Guertin, R. Lubarbe, S. Lucas, V. Métivier, F. Poirier, V. Potiron, F. Ralite, S. Rossomme, L. Schoenauen, E. Sterpin, F. Haddad
    2nd Flash Radiotherapy and Particle Therapy Conference, 30 November-2 Décember 2022, Barcelona, Spain
    hal-03885576